Welcome to NGC. Skip directly to: Search Box, Navigation, Content.

What's New > Guideline Archive > Updated NGC Summaries

Updated NGC Summaries

Use the index below to find guidelines (listed by guideline developer) that have been updated. Select "All" to see a complete list of updated NGC Guideline Summaries (organized alphabetically by guideline developer). In each case the withdrawn guideline has been replaced with a new/revised guideline. For a list of guidelines that have been permanently withdrawn from the site, go to Withdrawn NGC Summaries.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

The National Guideline Clearinghouse™ currently contains 1767 guidelines that have been superceded.

National Abortion Federation

  1. Clinical policy guidelines. (NGC-5572)
    • National Abortion Federation (NAF). Clinical policy guidelines. Washington (DC): National Abortion Federation (NAF); 2007. 48 p. [68 references]

    CURRENT NGC SUMMARY: Clinical policy guidelines. (NGC-6446)

National Academy of Clinical Biochemistry

  1. Recommendations for the use of cardiac markers in coronary artery diseases. (NGC-2745)
    • Wu AH, Apple FS, Gibler WB, Jesse RL, Warshaw MM, Valdes R Jr. National Academy of Clinical Biochemistry Standards of Laboratory Practice: recommendations for the use of cardiac markers in coronary artery diseases. Clin Chem 1999 Jul;45(7):1104-21. [119 references] PubMed

    CURRENT NGC SUMMARY: National Academy of Clinical Biochemistry laboratory medicine practice guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes. (NGC-6039)

    CURRENT NGC SUMMARY: National Academy of Clinical Biochemistry and IFCC Committee for standardization of markers of cardiac damage laboratory medicine practice guidelines: Analytical issues for biochemical markers of acute coronary syndromes. (NGC-6040)

    CURRENT NGC SUMMARY: National Academy of Clinical Biochemistry laboratory medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure. (NGC-6041)

    CURRENT NGC SUMMARY: National Academy of Clinical Biochemistry and IFCC Committee for standardization of markers of cardiac damage laboratory medicine practice guidelines: Analytical issues for biomarkers of heart failure. (NGC-6042)

    CURRENT NGC SUMMARY: National Academy of Clinical Biochemistry laboratory medicine practice guidelines: Point of care testing, oversight and administration of cardiac biomarkers for acute coronary syndromes. (NGC-6043)

    CURRENT NGC SUMMARY: National Academy of Clinical Biochemistry laboratory medicine practice guidelines: Use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type Natriuretic Peptide for Etiologies other than acute coronary syndromes and heart failure. (NGC-6044)

National Heart, Lung, and Blood Institute (U.S.)

  1. Expert Panel Report: guidelines for the diagnosis and management of asthma. Update on selected topics. (NGC-2721)
    • National Asthma Education and Prevention Program Expert Panel Report: guidelines for the diagnosis and management of asthma update on selected topics-2002. J Allergy Clin Immunol 2002 Nov;110(5 pt 2):S141-219.

    CURRENT NGC SUMMARY: Measures of asthma assessment and monitoring: Expert panel report 3: guidelines for the diagnosis and management of asthma. (NGC-5905)

    CURRENT NGC SUMMARY: Education for a partnership in asthma care: Expert panel report 3: guidelines for the diagnosis and management of asthma. (NGC-6021)

    CURRENT NGC SUMMARY: Control of environmental factors and comorbid conditions that affect asthma: Expert panel report 3: guidelines for the diagnosis and management of asthma. (NGC-6022)

    CURRENT NGC SUMMARY: Medications: Expert panel report 3: guidelines for the diagnosis and management of asthma. (NGC-6023)

    CURRENT NGC SUMMARY: Managing asthma long term in children 0-4 years of age and 5-11 years of age: Expert panel report 3: guidelines for the diagnosis and management of asthma. (NGC-6024)

    CURRENT NGC SUMMARY: Managing asthma long term in youths >12 years of age and Adults: Expert panel report 3: guidelines for the diagnosis and management of asthma. (NGC-6025)

    CURRENT NGC SUMMARY: Managing asthma long term-special situations: Expert panel report 3: guidelines for the diagnosis and management of asthma. (NGC-6026)

    CURRENT NGC SUMMARY: Managing exacerbations of asthma: Expert panel report 3: guidelines for the diagnosis and management of asthma. (NGC-6027)

  2. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. (NGC-2970)
    • Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 2003 May 21;289(19):2560-71. [81 references] PubMed

    CURRENT NGC SUMMARY: Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. (NGC-3450)

  3. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). (NGC-2195)
    • National Heart, Lung, and Blood Institute, National Institutes of Health, US Department of Health and Human Services. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Bethesda (MD): U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung and Blood Institute; 2001 May. Various p. [1274 references]

    CURRENT NGC SUMMARY: (1)Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). (2)Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. (NGC-3746)

National Institute for Health and Clinical Excellence (NICE)

  1. Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer’s disease. (NGC-5408)
    • National Institute for Health and Clinical Excellence (NICE). Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer's disease. London (UK): National Institute for Health and Clinical Excellence (NICE); 2006 Nov. 64 p. (Technology appraisal guidance; no. 111).

    CURRENT NGC SUMMARY: (1) Donepezil, galantamine, rivastigmine (review) and memantine for the treatment of Alzheimer's disease (2) 2007 addendum. (NGC-5956)

National Kidney Foundation

  1. NKF-K/DOQI clinical practice guidelines for hemodialysis adequacy: update 2000. (NGC-2007)
    • NKF-K/DOQI clinical practice guidelines for hemodialysis adequacy: update 2000. Am J Kidney Dis 2001 Jan;37(1 Suppl 1):S7-S64. [259 references]

    CURRENT NGC SUMMARY: NKF-K/DOQI clinical practice guidelines for hemodialysis adequacy: update 2006. (NGC-5329)

  2. NKF-K/DOQI clinical practice guidelines for peritoneal dialysis adequacy: update 2000. (NGC-2008)
    • NKF-K/DOQI clinical practice guidelines for peritoneal dialysis adequacy: update 2000. Am J Kidney Dis 2001 Jan;37(1 Suppl 1):S65-S136. [143 references]

    CURRENT NGC SUMMARY: NKF-KDOQI clinical practice guidelines for peritoneal dialysis adequacy: update 2006. (NGC-5330)

  3. NKF-K/DOQI clinical practice guidelines for vascular access: update 2000. (NGC-2009)
    • NKF-K/DOQI clinical practice guidelines for vascular access: update 2000. Am J Kidney Dis 2001 Jan;37(1 Suppl 1):S137-81. [209 references]

    CURRENT NGC SUMMARY: NKF-KDOQI clinical practice guidelines for vascular access: update 2006. (NGC-5331)

National Osteoporosis Foundation

  1. Physician's guide to prevention and treatment of osteoporosis. (NGC-1377)
    • National Osteoporosis Foundation. Physician's guide to prevention and treatment of osteoporosis. Belle Mead (NJ): Excerpta Medica, Inc.; 1999. 28 p.

    CURRENT NGC SUMMARY: Physician's guide to prevention and treatment of osteoporosis. (NGC-3073)

National Society of Genetic Counselors

  1. Genetic counseling for fragile X syndrome: recommendations of the National Society of Genetic Counselors. (NGC-1772)
    • McIntosh N, Gane LW, McConkie-Rosell A, Bennett RL. Genetic counseling for fragile X syndrome: recommendations of the National Society of Genetic Counselors. J Genet Counsel 2000;9(4):303-25.

    CURRENT NGC SUMMARY: Genetic counseling for fragile X syndrome: updated recommendations of the National Society of Genetic Counselors. (NGC-4730)

New York State Department of Health

  1. Antiretroviral therapy. (NGC-5881)
    • New York State Department of Health. Antiretroviral therapy. New York (NY): New York State Department of Health; 2007 Aug. 50 p. [18 references]

    CURRENT NGC SUMMARY: Antiretroviral therapy. (NGC-6653)

  2. Anxiety disorders in patients with HIV/AIDS. Mental health care for people with HIV infection. (NGC-4157)
    • Anxiety disorders in patients with HIV/AIDS. In: Mental health care for people with HIV infection: HIV clinical guidelines for the primary care practitioner. New York (NY): New York State Department of Health; 2001 Mar. p. 59-68.

    CURRENT NGC SUMMARY: Anxiety disorders in patients with HIV/AIDS. Mental health care for people with HIV infection. (NGC-4888)

  3. Cognitive disorders and HIV/AIDS: HIV-associated dementia and delirium. (NGC-4558)
    • New York State Department of Health. Cognitive disorders and HIV/AIDS: HIV-associated dementia and delirium. New York (NY): New York State Department of Health; 2005 Oct. 7 p. [6 references]

    CURRENT NGC SUMMARY: Cognitive disorders and HIV/AIDS: HIV-associated dementia and delirium. (NGC-6469)

  4. Depression and mania in patients with HIV/AIDS. Mental health care for people with HIV infection. (NGC-4155)
    • Depression and mania in patients with HIV/AIDS (updated online 2005 Mar). In: Mental health care for people with HIV infection: HIV clinical guidelines for the primary care practitioner. New York (NY): New York State Department of Health; 2001 Mar. p. 1-20.

    CURRENT NGC SUMMARY: Depression and mania in patients with HIV/AIDS. (NGC-6613)

  5. Diagnostic, prognostic, and resistance tests for HIV. (NGC-3936)
    • New York State Department of Health. Diagnostic, prognostic, and resistance tests for HIV. New York (NY): New York State Department of Health; 2004. 18 p.

    CURRENT NGC SUMMARY: Diagnostic, monitoring, and resistance tests for HIV. (NGC-4378)

  6. Drug-drug interactions between HAART, medications used in substance use treatment, and recreational drugs. (NGC-4452)
    • New York State Department of Health. Drug-drug interactions between HAART, medications used in substance use treatment, and recreational drugs. New York (NY): New York State Department of Health; 2005 Jul. 22 p. [57 references]

    CURRENT NGC SUMMARY: Drug-drug interactions between HAART, medications used in substance use treatment, and recreational drugs. (NGC-6471)

  7. Growth, body composition, and metabolism. (NGC-3930)
    • New York State Department of Health. Growth, body composition, and metabolism. New York (NY): New York State Department of Health; 2004. 25 p. [24 references]

    CURRENT NGC SUMMARY: Growth, body composition, and metabolism. (NGC-6474)

  8. Hepatitis A virus. (NGC-5758)
    • New York State Department of Health. Hepatitis A virus. New York (NY): New York State Department of Health; 2006 Apr. 4 p. [10 references]

    CURRENT NGC SUMMARY: Hepatitis A. (NGC-6466)

  9. Hepatitis B virus. (NGC-4534)
    • New York State Department of Health. Hepatitis B virus. New York (NY): New York State Department of Health; 2004 Sep. 12 p.

    CURRENT NGC SUMMARY: Hepatitis B virus. (NGC-6614)

  10. Hepatitis C virus. (NGC-3941)
    • New York State Department of Health. Hepatitis C virus. New York (NY): New York State Department of Health; 2003. 15 p. [14 references]

    CURRENT NGC SUMMARY: Hepatitis C virus. (NGC-4533)

  11. HIV drug - drug interactions. (NGC-5756)
    • New York State Department of Health. HIV drug-drug interactions. New York (NY): New York State Department of Health; 2007 Feb. 44 p. [34 references]

    CURRENT NGC SUMMARY: HIV drug - drug interactions. (NGC-6467)

  12. HIV post-exposure prophylaxis for children beyond the perinatal period. (NGC-3050)
    • New York State Department of Health. HIV post-exposure prophylaxis for children beyond the perinatal period. New York (NY): New York State Department of Health; 2002 Mar. 26 p. [36 references]

    CURRENT NGC SUMMARY: HIV post-exposure prophylaxis for children beyond the perinatal period. (NGC-3943)

  13. HIV prophylaxis following non-occupational exposure including sexual assault. (NGC-5745)
    • New York State Department of Health. HIV prophylaxis following non-occupational exposure including sexual assault. New York (NY): New York State Department of Health; 2005 Dec. 46 p. [31 references]

    CURRENT NGC SUMMARY: HIV prophylaxis following non-occupational exposure including sexual assault. (NGC-6475)

  14. HIV prophylaxis following occupational exposure. (NGC-5760)
    • New York State Department of Health. HIV prophylaxis following occupational exposure. New York (NY): New York State Department of Health; 2005 Dec. 44 p. [17 references]

    CURRENT NGC SUMMARY: HIV prophylaxis following occupational exposure. (NGC-6476)

  15. Identification and ambulatory care of HIV-exposed and -infected adolescents. (NGC-3942)
    • New York State Department of Health. Identification and ambulatory care of HIV-exposed and -infected adolescents . New York (NY): New York State Department of Health; 2003. 21 p. [22 references]

    CURRENT NGC SUMMARY: Identification and ambulatory care of HIV-exposed and -infected adolescents. (NGC-5759)

  16. Infectious complications associated with HIV infection: mycobacterial infections. (NGC-5747)
    • New York State Department of Health. Infectious complications associated with HIV infection: mycobacterial infections. New York (NY): New York State Department of Health; 2005 May. 20 p. [11 references]

    CURRENT NGC SUMMARY: Mycobacterial infections. (NGC-6468)

  17. Long-term complications of antiretroviral therapy. (NGC-3933)
    • New York State Department of Health. Long-term complications of antiretroviral therapy. New York (NY): New York State Department of Health; 2004. 17 p. [39 references]

    CURRENT NGC SUMMARY: Long-term complications of antiretroviral therapy. (NGC-5755)

  18. Oral health management of children and adolescents with HIV infections. (NGC-3035)
    • New York State Department of Health. Oral health management of children and adolescents with HIV infection. New York (NY): New York State Department of Health; 2003. 10 p. [6 references]

    CURRENT NGC SUMMARY: Oral health management of children and adolescents with HIV infections. (NGC-3891)

  19. Primary care approach to the HIV-infected patient. (NGC-3935)
    • New York State Department of Health. Primary care approach to the HIV-infected patient. New York (NY): New York State Department of Health; 2004. 18 p. [9 references]

    CURRENT NGC SUMMARY: Primary care approach to the HIV-infected patient. (NGC-5757)

  20. Smoking cessation in HIV-infected patients. (NGC-4450)
    • New York State Department of Health. Smoking cessation in HIV-infected patients. New York (NY): New York State Department of Health; 2005 Jun. 8 p. [17 references]

    CURRENT NGC SUMMARY: Smoking cessation in HIV-infected patients. (NGC-6472)

  21. Substance use treatment modalities for HIV-infected persons. (NGC-5753)
    • New York State Department of Health. Substance use treatment modalities for HIV-infected persons. New York (NY): New York State Department of Health; 2005 Jul. 11 p. [21 references]

    CURRENT NGC SUMMARY: Substance use treatment modalities for HIV-infected persons. (NGC-6473)

  22. Suicidality in patients with HIV/AIDS. Mental health care for people with HIV infection. (NGC-4156)
    • Suicidality in patients with HIV/AIDS. In: Mental health care for people with HIV infection: HIV clinical guidelines for the primary care practitioner. New York (NY): New York State Department of Health; 2001 Mar. p. 53-8.

    CURRENT NGC SUMMARY: Suicidality and violence in patients with HIV/AIDS. (NGC-5459)

  23. Trauma and post-traumatic stress disorder in patients with HIV/AIDS. Mental health care for people with HIV infection. (NGC-4158)
    • Trauma and post-traumatic stress disorder in patients with HIV/AIDS (updated online 2004 Sep). In: Mental health care for people with HIV infection: HIV clinical guidelines for the primary care practitioner. New York (NY): New York State Department of Health; 2001 Mar. p. 69-75.

    CURRENT NGC SUMMARY: Trauma and post-traumatic stress disorder in patients with HIV/AIDS. (NGC-6470)

  24. Working with patients' personalities and styles. Mental health care for people with HIV infection. (NGC-4152)
    • Working with patients' personalities and styles. In: Mental health care for people with HIV infection: HIV clinical guidelines for the primary care practitioner. New York (NY): New York State Department of Health; 2001 Mar. p. 19-23.

    CURRENT NGC SUMMARY: Personality disorders in patients with HIV/AIDS. Mental health care for people with HIV infection. (NGC-5002)

New Zealand Guidelines Group

  1. Primary care guidelines for the management of core aspects of diabetes care. (NGC-2336)
    • New Zealand Guidelines Group. Primary care guidelines for the management of core aspects of diabetes care. Wellington (NZ): New Zealand Guidelines Group (NZGG); 2000 Jun. 19 p. [41 references]

    CURRENT NGC SUMMARY: Management of type 2 diabetes. (NGC-3363)

North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition

  1. Constipation in infants and children: evaluation and treatment. (NGC-2821)
    • Baker SS, Liptak GS, Colletti RB, Croffie JM, Di Lorenzo C, Ector W, Nurko S. Constipation in infants and children: evaluation and treatment. A medical position statement of the North American Society for Pediatric Gastroenterology and Nutrition. J Pediatr Gastroenterol Nutr 1999 Nov;29(5):612-26. [77 references] PubMed

    CURRENT NGC SUMMARY: Evaluation and treatment of constipation in infants and children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. (NGC-5245)

North American Spine Society

  1. North American Spine Society Phase III: clinical guidelines for multidisciplinary spine care specialists. Spinal stenosis version 1.0. (NGC-2835)
    • North American Spine Society (NASS). Phase III clinical guidelines for multidisciplinary spine care specialists. Spinal stenosis version 1.0. LaGrange (IL): North American Spine Society (NASS); 2002. 91 p. [197 references]

    CURRENT NGC SUMMARY: Diagnosis and treatment of degenerative lumbar spinal stenosis. (NGC-5896)


Search Help
Detailed Search
Frequent Searches

What's New

» What's New This Week
» What's New Archive
» Guideline Index
» Guidelines In Progress
» Guideline Archive
» Manage Subscriptions